Anesthesia and Respiratory Devices Market Size to Hit USD 90.18 Bn by 2034

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Anesthesia and Respiratory Devices Market, By Product

7.1. Anesthesia and Respiratory Devices Market, by Product Type
7.1.1. Anesthesia Devices
7.1.1.1. Machines
7.1.1.2. Disposables
7.1.1.3. Market Revenue and Forecast
7.1.2. Respiratory Devices
7.1.2.1. Disposables
7.1.2.2. Equipment
7.1.2.3. Oxygen Concentrators
7.1.2.4. Market Revenue and Forecast
7.1.3. Measurement Devices
7.1.3.1. Spirometers
7.1.3.2. Pulse Oximeters
7.1.3.3. Capnography
7.1.3.4. Peak Flow Meters
7.1.3.5. Market Revenue and Forecast

Chapter 8. Global Anesthesia and Respiratory Devices Market, Regional Estimates and Trend Forecast

8.1. North America
8.1.1. Market Revenue and Forecast, by Product
8.1.2. U.S.
8.1.3. Rest of North America
8.1.3.1. Market Revenue and Forecast, by Product
8.2. Europe
8.2.1. Market Revenue and Forecast, by Product
8.2.2. UK
8.2.2.1. Market Revenue and Forecast, by Product
8.2.3. France
8.2.3.1. Market Revenue and Forecast, by Product
8.2.4. Rest of Europe
8.2.4.1. Market Revenue and Forecast, by Product
8.3. APAC
8.3.1. Market Revenue and Forecast, by Product
8.3.2. India
8.3.2.1. Market Revenue and Forecast, by Product
8.3.3. China
8.3.3.1. Market Revenue and Forecast, by Product
8.3.4. Japan
8.3.4.1. Market Revenue and Forecast, by Product
8.3.5. Rest of APAC
8.3.5.1. Market Revenue and Forecast, by Product
8.4. MEA
8.4.1. Market Revenue and Forecast, by Product
8.4.2. GCC
8.4.2.1. Market Revenue and Forecast, by Product
8.4.3. North Africa
8.4.3.1. Market Revenue and Forecast, by Product
8.4.4. South Africa
8.4.4.1. Market Revenue and Forecast, by Product
8.4.5. Rest of MEA
8.4.5.1. Market Revenue and Forecast, by Product
8.5. Latin America
8.5.1. Market Revenue and Forecast, by Product
8.5.2. Brazil
8.5.2.1. Market Revenue and Forecast, by Product
8.5.3. Rest of LATAM
8.5.3.1. Market Revenue and Forecast, by Product

Chapter 9. Company Profiles

9.1. Masimo Corporation
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. Medtronic
9.2.1. Company Overview
9.2.2. Product Offerings
9.2.3. Financial Performance
9.2.4. Recent Initiatives
9.3. AirSep Corporation
9.3.1. Company Overview
9.3.2. Product Offerings
9.3.3. Financial Performance
9.3.4. Recent Initiatives
9.4. Smiths Medical
9.4.1. Company Overview
9.4.2. Product Offerings
9.4.3. Financial Performance
9.4.4. Recent Initiatives
9.5. GE Healthcare
9.5.1. Company Overview
9.5.2. Product Offerings
9.5.3. Financial Performance
9.5.4. Recent Initiatives
9.6. Philips Healthcare
9.6.1. Company Overview
9.6.2. Product Offerings
9.6.3. Financial Performance
9.6.4. Recent Initiatives
9.7. B. Braun Medical Inc.
9.7.1. Company Overview
9.7.2. Product Offerings
9.7.3. Financial Performance
9.7.4. Recent Initiatives
9.8. Drägerwerk AG & Co
9.8.1. Company Overview
9.8.2. Product Offerings
9.8.3. Financial Performance
9.8.4. Recent Initiatives
9.9. KGaA
9.9.1. Company Overview
9.9.2. Product Offerings
9.9.3. Financial Performance
9.9.4. Recent Initiatives
9.10. Getinge AB
9.10.1. Company Overview
9.10.2. Product Offerings
9.10.3. Financial Performance
9.10.4. Recent Initiatives
9.11. Teleflex Inc
9.11.1. Company Overview
9.11.2. Product Offerings
9.11.3. Financial Performance
9.11.4. Recent Initiatives

Chapter 10. Research Methodology

10.1. Primary Research
10.2. Secondary Research
10.3. Assumptions

Chapter 11. Appendix

11.1. About Us
11.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The anesthesia and respiratory devices market size is expected to increase from USD 50.45 billion in 2025 to USD 90.18 billion by 2034.

The anesthesia and respiratory devices market is expected to grow at a compound annual growth rate (CAGR) of around 6.64% from 2025 to 2034.

The major players in the anesthesia and respiratory devices market include Masimo Corporation, Medtronic, AirSep Corporation, Smiths Medical, GE Healthcare, Philips Healthcare, Braun Medical Inc., Drägerwerk AG & Co, KGaA, Getinge AB, and Teleflex Inc

The driving factors of the anesthesia and respiratory devices market are the increasing number of surgical procedures in elderly patients, who are at higher risk of perioperative morbidity and mortality due to age-related physiological and pathological changes, is driving the growth of the anesthesia and respiratory devices market

North America region will lead the global anesthesia and respiratory devices market during the forecast period 2025 to 2034.